subject area of
- A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma Academic Article
- A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma Academic Article
- Acute asthma intervention: Insights from the STAY study Academic Article
- Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study Academic Article
- Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study Academic Article
- Advances in the treatment of mild asthma: recent evidence Academic Article
- An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma Academic Article
- As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma Academic Article
- Asthma quality of life during 1 year of treatment with budesonide with or without formoterol Academic Article
- Attenuation of Age-Related Muscle Wasting and Weakness in Rats After Formoterol Treatment: Therapeutic Implications for Sarcopenia Academic Article
- Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma Academic Article
- Budesonide/formoterol maintenance and reliever therapy versus conventional best practice Academic Article
- Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma Academic Article
- Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma Academic Article
- Chronic β2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Academic Article
- Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction Academic Article
- Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis Academic Article
- Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain Academic Article
- Daily Inhaled Corticosteroid Treatment Should Be Prescribed for Mild Persistent Asthma Academic Article
- Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations Academic Article
- Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Academic Article
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma Academic Article
- Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study Academic Article
- Effect of different asthma treatments on risk of cold-related exacerbations Academic Article
- Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma Academic Article
- Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators Academic Article
- Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma Conference Paper
- Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment Academic Article
- Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro Academic Article
- Exacerbations of Asthma Academic Article
- Formoterol Compared with Beclomethasone and Placebo on Allergen-induced Asthmatic Responses Academic Article
- Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Academic Article
- Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia Academic Article
- How much is too much? The treatment of mild asthma Academic Article
- Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control Academic Article
- Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma Academic Article
- Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury Academic Article
- Long-acting -agonists: a review of formoterol safety data from asthma clinical trials Academic Article
- Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma Academic Article
- Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue Academic Article
- Measuring asthma control: a comparison of three classification systems Academic Article
- Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial Academic Article
- Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps Academic Article
- Overall asthma control: The relationship between current control and future risk Academic Article
- Pharmacological management of mild or moderate persistent asthma Academic Article
- Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol Academic Article
- Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires Academic Article
- Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Academic Article
- Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Academic Article
- Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids Academic Article
- Safe use of long-acting β-agonists: what have we learnt? Academic Article
- Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials Academic Article
- Safety of formoterol in asthma clinical trials: an update Academic Article
- The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? Academic Article
- The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials Academic Article
- The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge Conference Paper
- The management of mild asthma Academic Article
- The paradoxes of asthma management: time for a new approach? Academic Article
- The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta‑analysis Academic Article
- Treatment Strategy for Asthma Academic Article
- What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever? Academic Article